These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25906485)

  • 1. Chromosomal ampC mutations in cefpodoxime-resistant, ESBL-negative uropathogenic Escherichia coli.
    Lewis JA; Moore PC; Arnold DL; Lawrance LM
    Br J Biomed Sci; 2015; 72(1):7-11. PubMed ID: 25906485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production.
    Caroff N; Espaze E; Bérard I; Richet H; Reynaud A
    FEMS Microbiol Lett; 1999 Apr; 173(2):459-65. PubMed ID: 10227175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
    Liebana E; Gibbs M; Clouting C; Barker L; Clifton-Hadley FA; Pleydell E; Abdalhamid B; Hanson ND; Martin L; Poppe C; Davies RH
    Microb Drug Resist; 2004; 10(1):1-9. PubMed ID: 15140388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and molecular characterization of AmpC-producing clinical isolates of Escherichia coli from southeastern Iran.
    Shayan S; Bokaeian M; Shahraki S
    Microb Drug Resist; 2014 Apr; 20(2):104-7. PubMed ID: 24224496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
    Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
    J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae.
    Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
    Microb Drug Resist; 2007; 13(3):186-90. PubMed ID: 17949305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals.
    Bogaerts P; Rodriguez-Villalobos H; Bauraing C; Deplano A; Laurent C; Berhin C; Struelens MJ; Glupczynski Y
    Pathol Biol (Paris); 2010 Feb; 58(1):78-83. PubMed ID: 19892478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an algorithm to discriminate between plasmid- and chromosomal-mediated AmpC β-lactamase production in Escherichia coli by elaborate phenotypic and genotypic characterization.
    Coolen JPM; den Drijver EPM; Kluytmans JAJW; Verweij JJ; Lamberts BA; Soer JACJ; Verhulst C; Wertheim HFL; Kolwijck E
    J Antimicrob Chemother; 2019 Dec; 74(12):3481-3488. PubMed ID: 31504559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of co-production of plasmid-mediated AmpC beta-lactamase and ESBL in cefoxitin-resistant uropathogenic Escherichia coli.
    Ghosh B; Mukherjee M
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1449-54. PubMed ID: 27250633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain.
    Castellanos LR; Donado-Godoy P; León M; Clavijo V; Arevalo A; Bernal JF; Timmerman AJ; Mevius DJ; Wagenaar JA; Hordijk J
    PLoS One; 2017; 12(1):e0170777. PubMed ID: 28125687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Occurrence of Extended-Spectrum β-lactamase-Producing Escherichia coli in Finnish Food-Producing Animals.
    Päivärinta M; Pohjola L; Fredriksson-Ahomaa M; Heikinheimo A
    Zoonoses Public Health; 2016 Dec; 63(8):624-631. PubMed ID: 27215423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in AmpC β-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013-2016).
    den Drijver E; Verweij JJ; Verhulst C; Oome S; Soer J; Willemsen I; Schrauwen EJA; Kluytmans-van den Bergh MFQ; Kluytmans JAJW
    PLoS One; 2018; 13(10):e0204864. PubMed ID: 30273375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli.
    Pascual V; Ortiz G; Simó M; Alonso N; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    J Antimicrob Chemother; 2015 Mar; 70(3):899-904. PubMed ID: 25468902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for extended-spectrum β-lactamase- and AmpC-producing Escherichia coli in dairy farms.
    Gonggrijp MA; Santman-Berends IMGA; Heuvelink AE; Buter GJ; van Schaik G; Hage JJ; Lam TJGM
    J Dairy Sci; 2016 Nov; 99(11):9001-9013. PubMed ID: 27638264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of fosfomycin resistance among isolates of Escherichia coli harboring extended-spectrum and AmpC β-lactamases.
    Bahramian A; Eslami G; Hashemi A; Tabibi A; Heidary M
    Acta Microbiol Immunol Hung; 2018 Mar; 65(1):15-25. PubMed ID: 29137487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.
    Alonso N; Miró E; Pascual V; Rivera A; Simó M; Garcia MC; Xercavins M; Morera MA; Espejo E; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E; Navarro F; Mirelis B; Coll P
    Int J Antimicrob Agents; 2016 Jan; 47(1):62-8. PubMed ID: 26607336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment.
    Siu LK; Lu PL; Chen JY; Lin FM; Chang SC
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2138-44. PubMed ID: 12821459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.